First Institute of All Medicines, a non-profit organization, obtained real world evidence that using Tesla BioHealing products can help people with Parkinson’s disease regain their life quality. Now we are seeking volunteers with Parkinson’s disease to participate in a non-invasive, triple-blinded study, using Tesla MedBed technology to further assess what life changing results are possible with these breakthrough products. Medical research staff at First Institute of All Medicines will be conducting this study. Tesla BioHealing will sponsor the study by providing the OTC medical devices and research facilities at Tesla MedBed Center, Pennsylvania.
Parkinson's disease (PD) is a complex progressive neurodegenerative disease described by James Parkinson in his 1817 publication, “Essay on the Shaking Palsy”. In that paper, Dr. Parkinson optimistically declared that “there appears to be sufficient reason for hoping that some remedial process may ere long be discovered, by which, at least, the progress of the disease may be stopped.” More than 200 years later the medical society has yet to definitively achieve neuroprotective therapy for PD. The National Institute of Health currently lists PD as a disease without a cure.
PD belongs to a group of conditions called motor system disorders, which cause unintended or uncontrollable movements of the body. The precise cause of PD is unknown, but some cases are hereditary while others are thought to occur from a combination of genetics and environmental factors that trigger the disease. In PD, brain cells become damaged or die in the part of the brain that produces dopamine, a chemical needed to produce smooth, purposeful movement.
Although PD currently has no cure, preliminary outcomes from those who used Tesla BioHealing products are very encouraging. This new study may pave the way for Tesla BioHealing technologies to be accepted as a standard of care for this condition. We look forward to collecting objective data and helping many more people with PD regain their quality of life.
Participants: 40 volunteers with Parkinson’s disease are needed to participate in this pioneering study.
Location and Duration: Tesla MedBed Center in Butler, Pennsylvania. 2-week live-in study in a hotel-like environment. Non-invasive, just sleep on a MedBed!
Procedures: Sleep nightly on a Tesla MedBed (or placebo) and complete life quality assessments. Health status information will be collected non-invasively by a medical professional. Those initially placed in the placebo group will have the opportunity to extend their stay to utilize a real Tesla MedBed once the initial phase of the study has been completed.
- Qualification: There will be a qualification process to participate in this study. If you are interested in participating, please email firstname.lastname@example.org with a copy of your clinical diagnosis of PD included to initiate the process. You are also welcome to reach out to us if you would like more information about participation.
The research team at First Institute of All Medicines and our team at Tesla BioHealing looks forward to hearing from you!
To learn more about Tesla BioHealing technology please review the following resources: